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Proteomic analysisProteoglycans encompass a heterogeneous group of glycoconjugates where proteins are substituted with
linear, highly negatively charged glycosaminoglycan chains. Sulphated glycosaminoglycans are ubiquitous to
the animal kingdom of the Eukarya domain. Information on the distribution and characterisation of
proteoglycans in invertebrate tissues is limited and restricted to a few species. By the use of multidimensional
protein identiﬁcation technology and immunohistochemistry, this study shows for the ﬁrst time the presence
and tissue localisation of different proteoglycans, such as perlecan, aggrecan, and heparan sulphate
proteoglycan, amongst others, in organs of the gastropoda Achatina fulica. Through a proteomic analysis of
Golgi proteins and immunohistochemistry of tissue sections, we detected the machinery involved in
glycosaminoglycan biosynthesis, related to polymer formation (polymerases), as well as secondary
modiﬁcations (sulphation and uronic acid epimerization). Therefore, this work not only identiﬁes both the
proteoglycan core proteins and glycosaminoglycan biosynthetic enzymes in invertebrates but also provides a
novel method for the study of glycosaminoglycan and proteoglycan evolution.Carl Peter von Dietrich.
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The complex structure and heterogeneity of the glycosaminoglycan
(GAG) chain play an important role in themyriad of biological functions
attributed to proteoglycans. The proteoglycan biosynthesis starts in the
late endoplasmatic reticulum and/or the cis-Golgi compartment [1–6],
with the xylosylation of speciﬁc serine residues on the core protein
[7–10]. The following step is the chain elongation by the action of
glycosyltransferases that successively transfer hexosamine and hex-
uronic acid. Distinct modiﬁcations at speciﬁc sites along the chain then
occur in the medial- and trans-Golgi compartments. For heparan
sulphate (HS) and heparin (HEP), speciﬁc modiﬁcations by different
types of enzymes occur: N-deacetylase-N-sulphotransferase, glucur-
onosyl C-5 epimerase, 2,3 and 6-O sulphotransferases, thereby
providing the enormous diversity of GAG chains which are requiredfor the different biological functions [11–15,65]. The heterogeneity of
the GAG chain is further regulated according to the cell cycle and cell–
cell contact, enabling interactions with different surface proteins and
effectors. The study of this complexbiosyntheticmachinery, responsible
for the synthesis of distinct GAG chains, is challenging and requires
novel analytical techniques for precise characterisation.
GAGs are distributed throughout the animal kingdom in both
vertebrate and invertebrate phylogenetic tree [16–19]. Acharan sulphate
(AS) is a GAG primarily isolated from the giant African snail (Achatina
fulica) composedofα-D-N-acetylglucosaminyl-2-O-sulpho-α-L-iduronic
acid repeating units, which relates to the structure of HEP and HS;
however, AS shows important differences to these GAGs [20–22]. For
instance, the glucosamine residue bearingN-acetyl substitution in theAS
chain contradicts the current GAG biosynthetic pathway theory, where
N-sulphation and epimerization precede 2-O-sulphation. Hence, A. fulica
is an interesting model for studying GAG biosynthesis [23,24].
Proteoglycans encompass a heterogeneous groupof glycoconjugates
where proteins are substituted with linear, highly negatively charged
GAG chains. Due to the presence of carboxyl and sulphate groups, GAGs
constitute a major source of macromolecular polyanions that surround
almost every cell type in metazoan organisms. Except for hyaluronic
acid, all GAGs occur in the tissues as proteoglycans [13,18,25,26]. GAGs
can be differentiated regarding the type of hexosamine and non-
nitrogenated sugar moieties, degree and position of sulphation, as well
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Sulphated GAGs are ubiquitous to the animal kingdom of the Eukarya
domain, whereas in the bacteria kingdom only non-sulphated chains of
GAGs are found. Sulphated GAGs are absent in protista, plantae, and
fungi. In the animal kingdom, the appearance of HS and CS coincides
with the emergence of eumetazoa, which are animals that display true
tissues. These compounds are ubiquitously found in all tissues and
species analysed. The occurrence ofDS is a late event in the evolutionary
GAG tree, being restricted to the appearance of deuterostomes. On the
other hand, the distribution of HEP is scattered throughout the
evolutionary tree, being found in some invertebrate and vertebrate
species [13,18,27–29]. Studies reporting diverse and novel glycan
structures have been described in invertebrates such as glucose
branches in chondroitin sulphate from squid cartilage, heparin-like
compounds in crab, and bivalve tissues and AS in A. fulica [4,27,30–34].
A number of biological functions have been proposed for AS in the snail
such as an antidesiccant and antibiotic molecule for protection of the
animal, as well as a role in locomotion and mobility, osmoregulation,
transport of divalent cations, and reproduction [35]. Moreover, AS can
act as an anti-angiogenic and tumour growth suppressor in cell and
animal models [14,15,36,37]. Interestingly, AS is not present in A. fulica
eggs; however, its content remarkably increases after hatching,
suggesting an important role in the snail growth but not in the initial
phases of development [38].The presence of proteoglycans in this snail
has not been described to date. Thus, in the present paper a proteomic-
based approach was used to study proteoglycans puriﬁed from the
whole body of the snail and results were conﬁrmed through
immunohistochemistry of key organs. Moreover, this proteomic
approach was also applied to a Golgi fraction puriﬁed from the whole
snail in an attempt to describe putative enzymes involved in GAG
synthesis, and the results were conﬁrmed through immunohistochem-
istry utilising antibodies that recognise these enzymes. The results
revealed for theﬁrst time thepresence and localisation of different types
of proteoglycans in A. fulica, aswell as the description and localisation of
GAG biosynthetic machinery in organs of the snail.2. Material and methods
2.1. Snail extracts
Animals were collected from the city of Santos (São Paulo, Brazil)
and processed after shell removal. The Animal Ethics Committee of
the University according to Brazilian animal care legislation approved
all experiments. For the proteoglycan extraction, the animals were
rinsed in cold phosphate buffered saline (67 mM phosphate and
150 mM NaCl, pH 7.0), soft body (mollusc without the shell content)
sliced with surgical blades on a glass plate and minced with 8 ml of
buffer A (50 mM Tris, pH 7.4, containing 7 M urea, 0.1 M NaCl, 1 μg/ml
aprotinine, 1 μg/ml leupeptine, 1 mM PMSF, 10 mM α-aminocaproic
acid, 1 mM EDTA, 1 mM benzamidine, 5 mM iodoacetamide, and
5 mM DTT) for 48 h at 4 °C. Afterwards, the samples were centrifuged
(3000 ×g, 5 min, 4 °C) in order to remove larger fragments. Aliquots
(0.1 ml) of the supernatant were used for total protein determination,
using the Bradford Reagent (Fermentas, Burlington, CA). For the
stacked Golgi isolation, the whole body of A. fulicawas ﬁnely dissected
and minced using surgical blades on a glass Petri dish, placed into a
50-ml conical tube on ice and suspended at a ratio of 1 g of minced
wet tissue per 2 ml of 0.5 M sucrose homogenization buffer (0.5 M
sucrose, 5 mM MgCl2, 0.1 M KH2PO4/K2HPO4 buffer, pH 6.7, and
complete protease inhibitor mixture 250 μl/50 ml) (Roche Applied
Science, Pleasanton, CA). The pieces were further homogenised using a
Polytron homogeniser PT 10–35 (Brinkmann Instruments, Westbury,
NY) for four cycles of less than 30 s and subjected to centrifugation
(1500 ×g for 10 min at 4 °C). The supernatant was collected on ice and
subjected to stacked Golgi isolation.2.2. Proteoglycan puriﬁcation and analysis
Proteoglycans were puriﬁed using Macro-Prep Q Support strong
anion exchange resin (Bio-Rad, Hercules, CA) as described [39]. Brieﬂy,
the supernatant obtained as described above was added to the resin
(5 ml supernatant/100 μl resin), incubated at 4 °C under rocking for
20 min and sedimented by centrifugation for 5 min at 3000 ×g. The
resin was then washed for 5 min with the following buffers: one wash
with buffer A (50 mM Tris, pH 7.4, containing 7 M urea, 0.1 M NaCl,
complete protease inhibitor mixture (Roche Applied Science), and
5 mMDTT), two washes with buffer B (buffer A plus 0.1 M NaCl), three
washeswith buffer C (6 Murea, 0.2 MNaCl, and 50mMsodium acetate,
pH 3.7) and ﬁnally two washes with buffer B. The proteoglycans were
eluted with 300 μl of 50 mM Tris, pH 7.4, 6 M urea and 1 M NaCl,
subjected to SDS-PAGE electrophoresis using a mini protein system
(Bio-Rad) and silver staining [40]. Proteoglycans were excised from the
gel, subjected to tryptic in-gel digestion [41] or proteinaseK (Invitrogen,
Carlsbad, CA) in gel digestion [42] and the peptides extracted and
separated using capillary columns (75-μm internal diameter by 10-cm
length) packed with 10 mg/ml POROS C18 resin (10-μm particle size)
(Applied Biosystems, Foster City, CA) in 100% acetonitrile with a high
pressure apparatus at 500 psi [43]. The quality of packing was
monitored in a stereomicroscope. Tryptic digested proteoglycan
samples were suspended in 10 μl 20% 2-propanol/0.2% formic acid and
loaded onto the capillary column connected to a nano-HPLC system
(1D-Plus) (Eksigent, Dublin, CA). The samples were eluted
(200 nl/min) in a gradient of 20–80% solvent B over 60 min (solvent
A: 5% 2-propanol/0.2% formic acid; solvent B: 90% 2-propanol/0.2%
formic acid) directly analysed in the nanospray source of a linear ion-
trap mass spectrometer (LXQ, Thermo Fisher Scientiﬁc, Waltham,
MA) as described in Section 2.5. A portion of the tryptic digested
peptides/glycopeptides was also submitted to β-elimination followed
by Michael addition with DTT [44]. Glycopeptides were incubated for
3 h at 50 °C in 20% ethanol, 10 mM DTT containing 0.1% NaOH and 1%
triethylamine. The reaction was quenched by addition of 1% triﬂuor-
oacetic acid ﬁnal concentration and the peptides extracted with
packaged POROS R1-10 resin by elution with 70% acetonitrile in 0.1%
triﬂuoroacetic acid.
2.3. Stacked Golgi isolation
The supernatant aliquots prepared from A. fulica as described
above were loaded onto a discontinuous sucrose step gradient [45].
Brieﬂy, the fraction was loaded into ultracentrifuge tubes between
layers of sucrose buffers of increasing densities, in the following
order: 2.5 ml 1.3 M sucrose, 3 ml 0.86 M sucrose, 4 ml supernatant
from A. fulica whole body extraction, and 3 ml 0.25 M sucrose. The
ultracentrifuge tubes containing the sucrose gradient and samples
were carefully transported to the ultracentrifuge (100,000 ×g, 1 h,
4 °C, set with the brakes turned off and slowest possible acceleration).
The SII interface (at 0.50/0.86 M) was collected using a wide bore
transfer pipette. This fraction, enriched in stacked Golgi, was adjusted
to 1.15 M sucrose using 2 M sucrose, layered at the bottom of the
second step gradient and overlaid with equal volumes of 1.0, 0.86 and
0.25 M sucrose and centrifuged at 76,000 ×g for 3 h at 4 °C. The
enriched Golgi fraction, located at the 0.25 M/0.86 M interface was
collected, diluted with an equal volume of 0.1 M KH2PO4/K2HPO4
buffer, pH 6.7, pelleted for 60 min at 150,000 ×g and stored at−80 °C.
2.4. Stacked Golgi proteins extraction and analysis
TheenrichedGolgi fractionwasdelipidatedbymethanol/chloroform
(4/1, v/v) extraction, and homogenised in a vortex. Double-distilled
water (ddH2O) was added to the mixture (3× the initial volume),
vortexed and microcentrifuged (16,000 ×g, 2 min). The upper aqueous
layer was removed, discarded and ddH2O (3× vol) added to the
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then pelleted in a microcentrifuge at maximum speed for 2 min,
suspended in 100 mM ammonium bicarbonate, pH 8.0, reduced with
5 mMDTT for 15 min at 50 °C, and the free thiol groups were alkylated
with 10 mM iodoacetamide for 30 min at room temperature light
protected andﬁnallydigested for 24 h at37 °Cwith1:100 ratioof 1 μg/μl
mass spectrometry-grade trypsin (Thermo Scientiﬁc, Hayward, CA)
[46]. Ten microliters of the digested Golgi fractions was analysed by
multidimensional protein identiﬁcation technology (MudPIT). Peptide
mixtures were ﬁrst separated by ion-exchange chromatography
(Nucleosil®-SA SCX column, 5 μm, 0.3 ID×150 mm, Macherey-Nagel
Inc., Bethlehem, PA, USA) using seven steps of increasing ammonium
chloride concentration (0, 50, 100, 150, 200, 300, and 600 mM). Each
salt step was directly loaded onto the reversed phase column
(Nucleosil-C18, 0.180 ID×100 mm, Bethlehem, PA, USA) and separated
with an acetonitrile gradient: eluent A, 0.1% formic acid inwater; eluent
B, 0.1% formic acid in acetonitrile. The samples were eluted (200 nl/
min) in a gradient of 20–80% solvent B over 60 min (solvent A: 5% 2-
propanol/0.2% formic acid; solvent B: 90% 2-propanol/0.2% formic
acid) directly analysed in the nanospray source of a linear ion-trap
mass spectrometer as described in Section 2.5.
2.5. Mass spectrometry
Tandem mass spectra were obtained on an LXQ linear ion-trap
mass spectrometer (Finnigan, Thermo Fisher Scientiﬁc, Waltham,
MA) at the Molecular Biology Program, Universidade Federal de
São Paulo, Brazil. Proteoglycans were excised from the bands after
SDS-PAGE separation, tryptic or proteinase K digested and
submitted to LC/MS/MS analysis. LXQ settings were as follows:
spray voltage of 1.8 kV, normal and zoom scan rates for full MS and
MS/MS, respectively, 1 microscan for MS scans at a maximum
inject time of 10 ms with a mass range of m/z 350–1400 and 3
microscans for MS/MS at a maximum inject time of 100 ms with
automatic mass range. The isolation width was setup to 2.0 m/z
and the activation Q parameter to 0.25, with activation time of
30 ms. A Dynamic Exclusion allowed one MS/MS scan per
precursor ion followed by a 40 s exclusion period. The LXQ was
operated in a data-dependent mode, that is, one MS scan for
precursor ions followed by four data-dependent MS/MS scans for
precursor ions above a threshold ion count of 500 with a
normalised collision energy value of 35%. The MS/MS spectra
obtained were used to search an UNIREF90 database (www.
uniprot.org) using Sequest version 27.9 [47], and data processing
and database searches were performed on Bioworks Browser 3.3.1
SP1 (Thermo Fisher Scientiﬁc). DTA ﬁles were generated from LC–Table 1
Identiﬁed proteoglycans from A. fulica extracts [a].
Protein name
(Uniref accession numbers)
Versican (UPI0000EB4193, UPI000057FE02, UPI0000EB4193)
TASSEEIHL, STAKATVPS[b], EPTTYVD, TVEGKEAFGP, PGTDAGMA
Perlecan (B1B0C7, UPI00006A1CD8, UPI00006A2F05, Q6KDZ1, UPI00015550)
GFTVEP, APASPAPI, GSPIYLE, YYKGPT, HSSLITP[b], NHHIVK, PPLYYHW,
GDRVHW[b], PLALLFF, HSSLITP[b], GKNVKP, HDSBEF[b], PGFYGDASAGT, YYKGPT
Aggrecan (UPI000069DE40, UPI0000F31294, Q95244)
IVPATAAPAEA, QTEAPGTA[b], SSGITFVDT[b], EEPRIT
CSPG3 (P79787, Q1LVV8,Q5ISN4, UPI000184A15A) [c]
AEWDSS*GARG, SVAPATPETT, PAMSTLASSSS, KILMEF
CSPG4-NG2 (UPI0001760E11, UPI00005A0919, Q6UVK1)
PPATLKVV, QLLVGGR, LALGQKEL, PSPRPERSI[b], RGLEVN, TIEDALLL,
MIQQPQGA
HSPG2 (UPI0001CBAD04, B2RZI0, UPI0000D9F8A3)[a]
LPVDIGSSAKSVV, YS*GRGD, NPKTGDPQ, S*GHCIPGDY
[a] The complete list of all peptides identiﬁed for each proteoglycan is included in the su
[b] Peptides from Proteinase K digests.
[c] Peptides with DTT tagging.MS/MS raw ﬁles with the following options: precursor ion
tolerance of 1.5 amu, group scan 1, minimum group count 1,
minimum ion count 20, and ﬁltering through charge state analysis.
The generated DTA ﬁles were searched against a composite target-
decoy database [48] composed by a subset delimited with the
strings sulphotransferase, epimerase and exostosis, for the search
against the glycosaminoglycan modifying enzymes. No subset was
used for proteoglycans database search. The database was
concatenated with the reverse sequences of all the proteins in
the database to allow for the determination of false-positive rates
with the following criteria: enzyme, trypsin (KR/P) or proteinase K
(depending of the enzyme used); full enzymatic cleavage; missed
cleavage sites, 3; peptide tolerance, 2.0 amu; fragment ion
tolerance, 1.0 amu; variable modiﬁcations, carbamidomethylation
(+57 Da), methionine oxidation (+16 Da); modiﬁcations per
peptide, 3. Those matches typically considered true matches had
ΔCn scores of at least 0.1 and XCorr values of 2.0 or greater for +1
and +2 charged peptides, and 3.5 or greater for +3 charged
peptides. For DTT modiﬁed peptides, a mass dynamic modiﬁcation
of 136.2 Da was set for serine and threonine residues. A mass
increase of 120.2 Da was also allowed for a cysteine when we
found that alkylated cysteines became derivatized using DTT.
Major peptides with modiﬁcations were as follows: chondroitin
sulphate (CSPG) (AEWDSS*GARG) and heparan sulphate proteo-
glycan (HSPG2) (YS*GRGD, S*GHCIPGDY). In cases in which more
than one commonly occurring peptide was used for a particular
proteoglycan, the signal intensities for the peptides were aver-
aged. Stacked Golgi proteins were analysed as described previ-
ously [45].
2.6. Immunohistochemistry
Organs (mucous gland, oviduct, intestine, and eye) of ﬁve
specimens of A. fulica were dissected and ﬁxed in 4% buffered
paraformaldehyde at 4 °C for 12 h, submerged in 30% sucrose for
24 h at 4 °C and embedded in tissue conditioning medium (Tissue
Tek, Sakura Finetek Inc., Torrance, CA). Tissue sections (4 μm)
were cut and washed in phosphate buffered saline (PBS) and
unspeciﬁc protein binding sites blocked with 5% foetal bovine
serum (FBS) in PBS for 30 min at 4 °C. The sections were then
incubated with speciﬁc primary antibodies: goat anti-EXT1 (Santa
Cruz sc-11040), goat anti-EXT2 (Santa Cruz sc-11045), mouse
anti-NDST1 (Abgent AT2995a), mouse anti-NDST1 (Abgent
AT2996a), mouse anti-epimerase (Abcam AB68714-50), rabbit
anti-HS2ST1 (Abgent AP7648c), rabbit anti-HS2ST1 (Abgent
AP2996a), rabbit anti-carbohydrate sulphotransferase 4-GolgiNo of peptides Predicted mass, kDa Sequence coverage %
14 370,872 6
5 422,479 4
4 125,304 6
4 111,989 7
7 222,692 4
4 371,316 3
pplemental material.
Fig. 1. Detection and localisation of versican, perlecan and heparan sulphate proteoglycan in tissues of A. fulica tissue sections. H&E staining and immunohistochemistry were
performed on sections of the mucous gland oviduct and foot prepared from A. fulica. Different proteoglycans (versican, perlecan and HSPG) were detected through
immunoﬂuorescence and analysed using a Zeiss LSM510 scanning confocal inverted microscope. The nuclei (blue) were stained with DAPI. The white scale bar represents 20 μm.
Images of H&E staining were obtained with an optical Nikon Eclipse E800 microscope. The blacks scale bar represents 20 μm.
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mouse anti-versican (Seikagaku), or mouse anti-HSPG (Seikagaku)
for 16 h at 4 °C in blocking solution. Negative control was
performed substituting the primary antibody with rabbit serum
and did not yield speciﬁc immunostaining. Afterwards, the
coverslips were washed three times in PBS and then incubated
for 1 h at room temperature with appropriate ﬂuorescent second-
ary antibodies produced in donkey conjugated to Alexa Fluor® 488
or Alexa Fluor® 594 (Molecular Probes/Invitrogen, Eugene, OR).
The nuclei were stained with 4,6-diamidino-2-phenylindole
(DAPI). After incubation with the antibodies, the coverslips were
washed three times in PBS, mounted on glass slides in Fluor-
omount G (2:1 in PBS, Electron Microscopy Sciences, Hatﬁeld, PA)
and sealed with nail polish. Coverslips were examined using aZeiss LSM510 scanning confocal inverted microscope and images
analysed using LSM Image Browser 3.2 software (Zeiss, Germany).
3. Results
3.1. Proteoglycans typical of vertebrate tissues are present in A. fulica
Proteoglycans (PGs) such as versican, perlecan, and aggrecan were
characterised for theﬁrst time in soft tissues of themolluscA. fulicausing
a proteomic approach (Table 1, Supplementary Table 1 and Supple-
mentary Fig. 1). From a total of 76 proteins and 271 peptides, twenty six
proteoglycan core proteins were identiﬁed, with approximately 1.5%
false discovery rate (FDR) at protein level. Perlecan and versican were
identiﬁed with 6% (5 peptides) and 4% (14 peptides) protein sequence
Table 2
Glycosaminoglycan biosynthetic enzymes of A. fulica identiﬁed by Golgi proteomics.
Protein name
(accession numbers)
No of
peptides
Predicted
mass, kDa
Sequence
coverage %
Heparan sulphate 2-O-sulphotransferase 41 24,479 26
(C4QHN0, D4I0001CBB25A, Q76KB1, Q86BJ3, Q8BUB6, UPI0000E48DC5, UPI0000EBD000, UPI0000ECC8D0, UPI00017588A1,
UPI000180C6DA, UPI000186E22F, UPI0001CB95A9, UPI0001CBAA90, UPI0001CBBC67, UPI0001CBBEAC, UPI0001CBBEAE)
Heparan sulphate 3-O-sulphotransferase 1 23 34,841 32
(Q6YLY0, UPI0000ECAC02, Q8IZT8, UPI0001C613BF, Q9Y661, A7UFE0, O35310, Q96QI5, UPI00003ADA1C, A0MGZ2)
Heparan sulphate 3-O-sulphotransferase 2 24 44,308 21
(UPI000180CE00, UPI0001CE1FE6, UPI000194C357, UPI00015B54E4, UPI0001CE1FE6, UPI0000F2C050, UPI0000F2D8AE,
UPI000194D530, UPI00015B54E4, UPI0001C613BF, A0MGY7, UPI000069DCC7)
Heparan sulphate 3-O-sulphotransferase 3 6 32,896 9
(A7UFE0, UPI0001CE1137, UPI00005A4371)
Heparan sulphate 3-O-sulphotransferase 4 (A0MGZ0,UPI0000E46D7A,UPI0000F2DDA5,UPI0000D9E188,UPI0000EBDBAC,
UPI0001CBB11F,UPI000180BB50,UPI0000DA1D7C)
16 48,227 16
N-deacetylase/N-sulphotransferase 1 34 113,157 23
(B0WMN5, C4Q3D0, C5BJN3, D2AWE5, Q3HKN9, Q9V3L1, UPI00003AD891, UPI000069EC32, UPI0000D9C374, UPI0000F2CA91,
UPI00015B5745, UPI0001760624, UPI000180BCFF, UPI000194D19A)
N-deacetylase/N-sulphotransferase 2 5 101,202 4.2
(P52850, Q2S3V4, O95803)
N-deacetylase/N-sulphotransferase 3 2 100,902 3
(O95803)
6-O-sulphotransferase 1 53 48,910 31
(A8NI06, C4PY10, O6024, Q56UJ5, Q76KB2, Q8UWB1, Q96MM7, Q9QYK5, Q9VDR6, UPI0000587151, UPI00005A0E4B,
UPI0000E4948D, UPI0000F2BBF4, UPI0000F2E085, UPI0000F2E110, UPI0000F2E643, UPI000155CF98, UPI000155E16F,
UPI00017EFB83, UPI000194CCD1, UPI0001CB9B74, UPI0001CBBE9A, UPI0001CE1620)
CS/DS 6-O-sulphotransferase 2 2 52,676 2.4
(Q9VDR6)
CS/DS 4-O-sulphotransferase 46 43,075 45
(B0W1J7, B0W401, B0WCF8, B1WBV7, B2GV63, B3DFJ6, B7QG53, Q08DS2, Q0D2D0, Q17NH2, Q28E26, UPI00006A5799,
UPI0000D9454A, UPI0000F1D2AB, UPI00015B59E2, UPI0001797BBA, UPI000180BF19, UPI000194D354, UPI0001CE30CB)
CS/DS 3-O-sulphotransferase 29 41,002 37
(B7PMT6, UPI00006A5E7A, UPI0000DA3209, UPI0000F2E32F, UPI0001CB9EAF, UPI0001CBA2ED, UPI0001CBA313,
UPI0001CBB043, UPI0001CBB512, UPI0001CBB6BE, UPI0001CBBB07, UPI0001CBBDFD)
KS 6-O-sulphotransferase 16 40,058 42
(UPI0000521A98, UPI00006A431D, UPI000180B495, UPI0001CBA1F2, UPI0001CBBA9A)
EXT 1 1 74,050 4.2
(UPI00006A127A)
EXT 2 32 74,527 21
(Q28F88, Q3TPI7, A0JN91, C9JU51, UPI000154D9B6, UPI00015DF52C)
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showed 2 putative GAG attachment sites (AEWDSS*GARG and
SSG*ITFVDT) with 6% sequence coverage in the 4 peptides found.
Chondroitin sulphate proteoglycan-3 and -4 (Neuroglycan-NG2) were
also found in the proteoglycan extracts with predicted molecular
masses of 112 and 222 kDa and sequence coverage of 7 and 4%,
respectively. Molluscs contain HS chains similar to those found in
vertebrates [32]. Using the present methodology we were able to
identify a heparan sulphate proteoglycan (HSPG2) with sequence
coverage of 3% in 5 peptides found. Furthermore, putative attachment
sites (YS*GRGD and S*GHCIPGDY) were identiﬁed for two of those
peptides by DTT tagging.3.2. Proteoglycans tissue distribution in A. fulica revealed by
immunohistochemistry
Perlecan and versican were distributed throughout the integu-
ment of A. fulica. A similar pattern has been described for collagen
type-I in other gastropods [49]. Our results showed that these PGs
were localised in the extracellular matrix (ECM) of the subepidermal
connective tissue. For perlecan, the distribution was occasionally
thickened into clumps or irregularly branching forms with an intense
meshwork of reactivity (Fig. 1). The reactivity for both versican and
perlecan was particularly strong in the mucous gland, oviduct, and
foot. HSPG was detected in all organs analysed; however, the
distribution of this proteoglycan was strong and organised in the
mucous gland and oviduct, with substantial immunoreactivity in the
acinar epithelial cells, as well as, a lamellar distribution throughout
the organs. HSPG was also strongly detected in the stromasurrounding the acinar glands and this distribution was thickened
into clumps. The distribution of HSPG suggests a role in the support of
the acinar epithelial cells, possibly forming a basal membrane
surrounding this structure. In the oviduct, mucous gland and foot
the versican antibody staining showed intense meshwork of positive
staining with strong immunoreactivity in the foot between bundles of
muscle ﬁbres (Fig. 1).
3.3. Enzymes involved in GAG biosynthesis discovered by peptide
analysis of A. fulica Golgi extracts
An initial assessment of GAG biosynthetic machinery in the whole
body of A. fulica was performed on enriched Golgi fractions and
analysed by multidimensional protein identiﬁcation technology
(MudPIT) LC–MS/MS. From 1032 total peptide sequences found, we
found 384 peptides from A. fulica which were matched to 118 GAG
biosynthetic proteins (Table 2 and Supporting information Table 2).
With the exception of glucuronosyl C5-epimerase, peptides were
found for all enzymes responsible for heparan sulphate/heparin
biosynthesis. Enzymes putatively related to chondroitin sulphate (CS)
and dermatan sulphate (DS) synthesis were also detected.
3.4. Glycosaminoglycan biosynthetic enzymes in A. fulica tissues
revealed by immunohistochemistry
Glycosaminoglycan biosynthetic enzymes showed remarkable
distribution in the oviduct and mucous gland tissues, surrounding
acinar and bundles of muscle ﬁbre, being particularly numerous in the
gastropod integument (Fig. 2). The staining of heparan sulphate 2-O-
Fig. 2. Detection and localisation of enzymes involved in heparan sulphate biosynthesis in A. fulica tissue sections. Immunohistochemistry analysis was performed on mucous gland
and oviduct tissue sections prepared from A. fulica and different enzymes involved in heparan sulphate biosynthesis investigated by immunohistochemistry. EXT1 (heparan sulphate
polymerase 1), EXT2 (heparan sulphate polymerase 2), 2OST (heparan sulphate 2-O-sulphotransferase), NDST1 (heparan sulphate N-deacetylase/N-sulphotransferase 1) and Epi
(glucuronosyl C5-epimerase) were detected with Alexa 488 (green) and Carbohydrate sulphotransferase-4 (Golgi marker) detected with Alexa 594 (red) with exception to EXT1 in
the mucous gland. Co-localisation of channels is represented in yellow. Immunoﬂuorescence was detected using a Zeiss LSM510 scanning confocal inverted microscope. The nuclei
(blue) were stained with DAPI. Scale bar represents 20 μm.
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discontinuous in the connective tissue. Glucuronosyl C5-epimerase
antibody staining was present in the zone between the epithelium
and the underlying connective tissue but occasionally concentrated
into irregular clumps (Fig. 2 and Supplementary Fig. 2). Similar
staining proﬁle was observed for the heparan sulphate polymerases
(EXT1 and EXT2). The NDST antibody staining was discontinuous and
irregular (Fig. 2 and Supplementary Fig. 2). All GAG biosynthetic
enzymes investigated herein colocalised with carbohydrate sulpho-
transferase 4, which is a Golgi marker, thus conﬁrming the Golgi
localisation for these enzymes.
4. Discussion
The diversity in structure and speciﬁc cellular and tissue distribution
indicates that these glycoconjugates could perform different biological
roles. Indeed, pivotal functions have been postulated for proteoglycans
and their GAG moieties, such as organisation and modulation of the
extracellular matrix, tissue morphogenesis and differentiation, cellular
adhesion and recognition, amongst others [26,50]. Nevertheless, the
information on the distribution and characterisation of proteoglycans in
invertebrate tissues is limited and restricted to a few species [50–56].
Our data shows for the ﬁrst time the presence and tissue localisation of
different proteoglycans in organs of the gastropoda A. fulica. Further-
more, these proteoglycans show tissue distribution and structural
characteristics similar to those found in vertebrate species. Thus, the
presence of versican, a CS proteoglycan classically of the ECM, was
detected in the snail tissues through immunohistochemistry, showing
the same type of arrangement ﬁrst described for collagens in other
molluscs [57]. Perlecan, another CS or HS proteoglycan from ECM was
also clearly demonstrated in the tissues analysed, presenting a similar
distribution. Furthermore, the core proteins for these PGs were
conﬁrmed by proteomic analysis. The presence of HSPG, a classic cellmembraneproteoglycan,was identiﬁed through immunohistochemistry
at the cell surface as described for vertebrate species. Furthermore, other
ECM PGs, such as aggrecan (CSPG-1) and neurocan (CSPG-3), and
neuroglycan (CSPG4-NG2), a transmembrane PG, were detected solely
through proteomic analysis. These combined data are indicative of the
strong relationship between invertebrate and vertebrate proteoglycans,
thereby suggesting a common pattern of biological activity in
invertebrates.
Regarding the enzymes involved in GAG biosynthesis, our results
clearly demonstrated both by the peptide proﬁling from Golgi
proteins as well as tissue localisation by immunohistochemistry that
the snail has the complete biosynthetic machinery necessary to
synthesise HS, HEP, as well as AS. We were able to show the enzymes
involved in the initial steps of polymer formations (polymerases I and
II, EXT 1 and EXT 2) as well as the ones related to secondary
modiﬁcations, such asN-deacetylation/N-sulphation of the glucosamine
moiety, epimerization of the β-D-glucuronic acid to α-L-iduronic acid,
and O-sulphation at various positions of the polymer chain, that is, at the
uronic acid and theglucosaminemoieties (2OST, 3OST, 6OST). Regarding
the biosynthetic machinery for CS, using the proteomic analysis we
showed the presence of different sulphotransferases. Therefore, our
novel technique of Golgi proteomics of A. fulica revealed the presence of
conserved GAG biosynthetic machinery [16,58–64].
5. Conclusion
Limiting factors of proteomic approaches include the subsequent
characterisation of the identiﬁed proteins and the amount of false
positive results due to the lack of a robust data analysis and validation.
This can be even greater when one studies molecules from a new
model, wheremost of the data need further validation. In contrast, our
present study not only identiﬁes GAG biosynthetic enzymes through
proteomic analysis of stacked Golgi isolation and provides further
1868 T.F. Gesteira et al. / Biochimica et Biophysica Acta 1814 (2011) 1862–1869information on the machinery involved, but also provides a novel
method for the study related to GAG and proteoglycan evolution.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbapap.2011.07.024.
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